Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity

References

• Luu AZ, Chowdhury B, Al-Omran M, Teoh H, Hess DA, Verma S. Role of endothelium in doxorubicin-induced cardiomyopathy. JACC Basic Transl Sci. 2018 Dec 31;3(6):861–70. doi: 10.1016/j.jacbts.2018.06.005.
   PubMedGoogle Scholar
• Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin cardiomyopathy. Cardiology. 2010;115:155–62.doi:10.1159/000265166.
   PubMed Web of Science ®Google Scholar
• Mitry MA, Edwards JG. Doxorubicin induced heart failure: phenotype and molecular mechanisms. Int J Cardiol Heart Vasc. 2016;10:17–24.doi:10.1016/j.ijcha.2015.11.004.
   PubMed Web of Science ®Google Scholar
• Canan G. Nebigil* and laurent désaubry. Updates in anthracycline-mediated cardiotoxicity. Front Pharmacol. 2018;9:1262.doi:10.3389/fphar.2018.01262.
   PubMed Web of Science ®Google Scholar
• Govender J, Loos B, Marais E, Engelbrecht AM. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. J Pineal Res. 2014 Nov;57(4):367–80. doi:10.1111/jpi.12176.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicininduced cardiotoxicity via activating AKT. Cell Death Differ. Forthcoming. doi: 10.1038/s41418-019-0372-z.
   Google Scholar
• Lebrecht D, Walker UA. Role of mtDNA lesions in anthracycline cardiotoxicity. Cardiovasc Toxicol. 2007;7:108–13.doi:10.1007/s12012-007-0009-1.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu Y, Hua S, Zhou S, Wang K. ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress. Int J Clin Exp Med. 2015;8:6794–803.
   PubMed Web of Science ®Google Scholar
• Tong Z, Jiang B, Wu Y, Liu Y, Li Y, Gao M, Jiang Y, Lv Q, Xiao X. MiR-21 protected cardiomyocytes against doxorubicin- induced apoptosis by targeting BTG2. Int J Mol Sci. 2015;16:14511–25.doi:10.3390/ijms160714511.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Takeshige N, Miura N, Morimoto Y, Ito T, Tancharoen S, Miyata K, Kikuchi C, Iida N, Uchikado H, et al. Beyond free radical scavenging: beneficial effects of edaravone (radicut) in various diseases (review). Exp Ther Med. 2012;3:3–8.doi:10.3892/etm.2011.352.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Miura N, Kawahara K, Murai Y, Morioka M, Lapchak PA, Tanaka E. Edaravone (radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke (review). Biomed Rep. 2013;1:7–12.doi:10.3892/br.2012.7.
   PubMedGoogle Scholar
• Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther. 1994;268:1597–604.
   PubMed Web of Science ®Google Scholar
• Wu TW, Zeng LH, Wu J, Fung K-P. Myocardial protection of MCI-186 in rabbit ischemia- reperfusion. Life Sci. 2002;71:2249–55.doi:10.1016/s0024-3205(02)01965-3.
   PubMed Web of Science ®Google Scholar
• Yao K, Shirakura S. Combined effects of benidipine and diltiazem in a rat model of experimental angina. J Pharmacol Sci. 2004;95:394–97.doi:10.1254/jphs.sc0030119.
   PubMed Web of Science ®Google Scholar
• Matsubara M, Yao K, Hasegava K. Benidipine, a dihydropyridine-calciumchannel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release. Pharmacol Res. 2006;3:35–43.doi:10.1016/j.phrs.2005.08.006.
   Google Scholar
• Cruz MP.Edaravone (radicava) a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis. Pharm Ther. 2018;43(1):25–28.
   Google Scholar
• Drug bank. [accessed 2019 Sep 15]. https://www.drugbank.ca/drugs/DB09231.
   Google Scholar
• Kaushik D, Khan SA, Chawla G, Kumar S. Nꞌ-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4- yl)methylene]2/4-substitutedhydrazides: synthesisandanticonvulsantactivity. EurJ MedChem. 2010;45:3943–49.
   Web of Science ®Google Scholar
• Akhtar MS, Pillai KK, Hassan MQ, Dhyani N, Ismail MV, Najmi AK. Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway. Life Sci. 2016;153:55–65.doi:10.1016/j.lfs.2016.03.049.
   PubMed Web of Science ®Google Scholar
• Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1970;34:30–38.doi:10.1016/0003-2697(70)90083-7.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205.doi:10.1016/0003-2697(68)90092-4.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WV. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69.
   PubMed Web of Science ®Google Scholar
• Horn HD, Burns GH. Assay of glutathione reductase activity. In: Bergmeyer HV, editor. Methods of enzymatic analysis. NewYork: Academic Press; 1978. p. 142.
   Google Scholar
• Habig WH, Pabst MJ, Jacob WB. Glutathione S-transferase, the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–39.
   PubMed Web of Science ®Google Scholar
• Marklund S, Marklund G. Involvement of superoxide anion radical in auto oxidation by pyrogallol and a convenient assay of superoxide dismutase. Eur J Biochem. 1974;47:469–74.doi:10.1111/j.1432-1033.1974.tb03714.x.
   PubMedGoogle Scholar
• Claiborne A. Catalase activity. In: Greenwald RA, editor. Handbook of methods for oxygen free radical research. Boca Raton, FL: CRC Press; 1985. p. 283–84.
   Google Scholar
• Lowry OH, Rosebrough NH, Farr AL, RANDALL RJ. Protein measurements with the folin phenol reagent. J Biol Chem. 1951;193:265–75.
   PubMed Web of Science ®Google Scholar
• Jhonson D, Lardy H. Isolation of liver and kidney mitochondria. In: Estrabrook RW, editor. Methods in Enzymology. Vol. 10. London: Academic Press; 1967. p. 94–96.
   Google Scholar
• Reed LJ, Mukherjee RB. Alpha ketoglutarate dehydrogenase complex from eshcherichia coli. In: Lowenstein JM, editor. Methods in enzymology. London: Academic Press; 1969. p. 53–61.
   Google Scholar
• Pearl W, Caocaranoj BW. Micro determination of cytochrome oxidase in rat tissues by the oxidation of N-phenyl-phyenylenediamine or ascorbic acid. J Histochem Cytochem. 1963;11:102–07.doi:10.1177/11.1.102.
   Web of Science ®Google Scholar
• Mehler AH, Konberg A, Grisolia S, Ochoa S. The enzymatic mechanism of oxidation reductions between malate or isocitrate or pyruvate. J Biol Chem. 1948;174:961–77.
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU. Method of enzymatic analysis. 2nd ed,Vol.2. Academic press; 1974.p.624–27.
   Google Scholar
• Bhatia J, Tabassum F, Sharma AK, Bharti S, Golechha M, Joshi S, Sayeed Akhatar M, Srivastava AK, Arya DS.Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol. 2011;11(3):272–79.doi:10.1007/s12012-011-9122-2.
   PubMed Web of Science ®Google Scholar
• Lie JT, Pairolero PC, Holley KE, Titus JL. Macroscopic enzyme mapping verification of large, homogenous experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiov Sur. 1975;69:599–605.
   PubMed Web of Science ®Google Scholar
• Belur B, Kandaswamy N, Mukherjee KL. Laboratory technology – A procedure manual for routine diagnostic tests. Vol. 2. Delhi-2: Tata Mc Graw Hill Co. Ltd; 1990. p. 1124–88.
   Google Scholar
• Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand J-B, Gibbs H, Zafarmand AA, Ewer MS. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109:3122–31.doi:10.1161/01.CIR.0000133187.74800.B9.
   PubMed Web of Science ®Google Scholar
• Rashikh A, Pillai KK, Ahmad SJ, Akhtar M, Najmi AK. Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury. J Renin Angiotensin Aldosterone Syst. 2013;14:14–22.doi:10.1177/1470320312459980.
   PubMed Web of Science ®Google Scholar
• Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977;197:165–67.doi:10.1126/science.877547.
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Takizawa S, Shimada S, Tokudome T, Shindo T, Matsumoto K. Effects of adrenomedullin on doxorubicin- induced cardiac damage in mice. Biol Pharm Bull. 2016;39:737–46.doi:10.1248/bpb.b15-00832.
   PubMed Web of Science ®Google Scholar
• Kumar D, Kirshenbaum LA, Li T, Danelisen I, Singal PK. Apoptosis in Adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal. 2001;3:135–45.doi:10.1089/152308601750100641.
   PubMed Web of Science ®Google Scholar
• Schunke KJ, Coyle L, Merrill GF, Denhardt DT.Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels. J Cell Physiol. 2013;228(10):2006–14.doi:10.1002/jcp.24367.
   PubMed Web of Science ®Google Scholar
• Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34.doi:10.1186/1741-7015-8-34.
   PubMed Web of Science ®Google Scholar
• Deepa PR, Varalakshmi P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chemico-Biol Interact. 2003;146:201–10.doi:10.1016/j.cbi.2003.08.003.
   PubMed Web of Science ®Google Scholar
• Gnanapragasam A, Ebenezar KK, Sathish V, Govindaraju P, Devaki T. Protective effect of centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats. Life Sci. 2004;76:585–97.doi:10.1016/j.lfs.2004.09.009.
   PubMed Web of Science ®Google Scholar
• Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promote endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation. 1994;89:2829–35.doi:10.1161/01.cir.89.6.2829.
   PubMed Web of Science ®Google Scholar
• Koti BC, Nagathan S, Vishwanathswamy A, Gadad PC, Thippeswamy A. Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological study. Pharmacogn Mag. 2013;9:176–81.doi:10.4103/0973-1296.111287.
   PubMed Web of Science ®Google Scholar
• Kwatra M, Kumar V, Jangra A, Mishra M, Ahmed S, Ghosh P, Vohora D, Khanam R. Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats. Pharm Biol. 2015;16:1–11.
   Google Scholar
• Doroshow JH, Davies KJ. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem. 1986;261:3068–74.
   PubMed Web of Science ®Google Scholar
• Dey S, DeMazumder D, Sidor A, Foster DB. O’Rourke B.Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure. Circ Res. 2018;123:356–71.doi:10.1161/CIRCRESAHA.118.312708.
   PubMed Web of Science ®Google Scholar
• Clementi ME, Giardina B, Di Stasio E, Mordente A, Misiti F. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Res. 2003;23:2445–50.
   PubMed Web of Science ®Google Scholar
• Ueno H, Hara T, Ishi A, Shuto K. Effects of benidipine hydrochloride on cerebrovascular lesions in salt-loaded stroke-pronespontaneously hypertensive rats: evaluation by magnetic resonance imaging. Jpn J Pharmacol. 2000;84:56–62.doi:10.1254/jjp.84.56.
   PubMedGoogle Scholar
• Renu K, Abilash VG, Tirupathi PPB, Arunachalam S. Molecular mechanism of doxorubicin-induced cardiomyopathy -An update. Eur J Pharmacol. 2018;818:241–53.doi:10.1016/j.ejphar.2017.10.043.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kribbs S, Clubb F, Michael L, Didenko V. Pathophysiological relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97:1382–91.doi:10.1161/01.cir.97.14.1382.
   PubMed Web of Science ®Google Scholar
• Zanwar A, Hegde M, Bodhankar S. Protective role of concomitant administration of flax lignin concentrate and omega-3-fatty acid on myocardial damage in doxorubicin- induced cardiotoxicity. Food Sci Human Well. 2013;2:29–38.doi:10.1016/j.fshw.2013.01.002.
   Google Scholar
• Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52:1213–25.doi:10.1016/j.yjmcc.2012.03.006.
   PubMed Web of Science ®Google Scholar
• Jieli L, Qing M. Early detection of doxorubicin-induced cardiotoxicity with high-sensitivity troponin T in chemotherapy-treated patients. Am J Clin Pathol. 2018 October;150(Issue suppl_1):S162. doi:10.1093/ajcp/aqy112.376.
   PubMedGoogle Scholar
• Rohilla A, Ahmad A, Khan MU,  Khanam R. A comparative study on the cardioprotective potential of atorvastatin and simvastatin in hyperhomocysteinemic rat hearts. Eur J Pharmacol. 2015;764:48–54.
   PubMed Web of Science ®Google Scholar